Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions
In Sweden, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and replaced by the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or the 13-valent PCV (PCV13) from late 2009. We assessed the impact of PCVs on rates of antibiotic prescribi...
Saved in:
Main Authors: | Mark Edmondson-Jones (Author), Therese Dibbern (Author), Marcus Hultberg (Author), Bengt Anell (Author), Emma Medin (Author), Yang Feng (Author), Carla Talarico (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions
by: Mark Edmondson-Jones, et al.
Published: (2021) -
Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era
by: Saurabh Talathi MD, MPH, et al.
Published: (2017) -
Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia
by: Gabriel Carrasquilla, et al.
Published: (2021) -
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
by: Patricia Izurieta, et al.
Published: (2022) -
An economic evaluation of nivolumab for the treatment of squamous and non-squamous NSCLC in the Swedish setting
by: Caitlin Smare, et al.
Published: (2019)